cromolyn sodium has been researched along with Flushing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castells, MC; Liu, A; Ross, JJ; Saavedra, A; Vleugels, RA | 1 |
| Worobec, AS | 1 |
1 review(s) available for cromolyn sodium and Flushing
| Article | Year |
|---|---|
Treatment of systemic mast cell disorders.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents; Aspirin; Cholinergic Antagonists; Clinical Trials as Topic; Combined Modality Therapy; Contraindications; Cromolyn Sodium; Diphosphonates; Flushing; Follow-Up Studies; Hematologic Diseases; Histamine Antagonists; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Leukemia, Mast-Cell; Mast-Cell Sarcoma; Mastocytosis; Osteoporosis; Photochemotherapy; Proto-Oncogene Proteins c-kit; Recombinant Proteins; Skin Neoplasms; Treatment Outcome | 2000 |
1 other study(ies) available for cromolyn sodium and Flushing
| Article | Year |
|---|---|
Interactive medical case. A rash hypothesis.
Topics: Acetates; Adult; Anti-Inflammatory Agents; Cromolyn Sodium; Cyclopropanes; Diarrhea; Drug Therapy, Combination; Enzyme Inhibitors; Exanthema; Female; Flushing; Histamine H2 Antagonists; Humans; Leukotriene Antagonists; Mastocytosis, Systemic; Prednisone; Protein-Tyrosine Kinases; Quinolines; Ranitidine; Staurosporine; Sulfides; Tryptases; Vomiting | 2010 |